<DOC>
	<DOCNO>NCT02679287</DOCNO>
	<brief_summary>The purpose study use investigational type technology call Closed-Loop Control ( CLC ) Medical Platform System help control blood sugar people type 1 diabetes mellitus home setting .</brief_summary>
	<brief_title>Project Nightlight : Efficacy System Acceptance Dinner/Night vs. 24hr Closed Loop Control</brief_title>
	<detailed_description>The CLC deploy different functionality different stage trial , result variation subject responsible system drive.These functionality occur randomize cross-over design , occur 8 week . These modality : 1 . SAP=sensor-augmented pump 2 . USS+SAP ( ) = SAP day CLC start dinner continue overnight 3 . USS+CLC ( ) = 24-hour Day Night Closed Loop Control The closed loop control system 's new version , inControl Diabetes Management Platform , test 48-hour Pilot study onset trial . This AP system remain smartphone-based , artificial pancreas platform automatically control insulin delivery .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>type 1 diabetes least one year use insulin least 1 year insulin pump least 6 month medical condition treat medication might interfere study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Closed-Loop Control ( CLC )</keyword>
	<keyword>Sensor-Augmented Therapy ( SAP )</keyword>
	<keyword>USS Virginia</keyword>
	<keyword>Continuous Glucose Monitor ( CGM )</keyword>
	<keyword>Insulin Pump</keyword>
	<keyword>Artificial Pancreas ( AP )</keyword>
</DOC>